Atherogenic lipoproteins and diabetes mellitus

This publication has 25 references indexed in Scilit:

• Long-term efficacy of bezafibrate in reduction of small, dense low-density lipoprotein by hypotriglyceridemic action
  Current Therapeutic Research, 2000
• Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia
  Atherosclerosis, 1999
• Troglitazone and Small Low-Density Lipoprotein in Type 2 Diabetes
  Annals of Internal Medicine, 1998
• Remnant-like Particle Cholesterol Levels in Patients with Dysbetalipoproteinemia or Coronary Artery Disease
  The American Journal of Medicine, 1998
• Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy
  Atherosclerosis, 1996
• LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
  Circulation, 1990
• Low-density lipoprotein subclass patterns and risk of myocardial infarction
  JAMA, 1988